T cell responses to SARS-CoV-2 spike cross-recognize Omicron - Nature

Indonesia Berita Berita

T cell responses to SARS-CoV-2 spike cross-recognize Omicron - Nature
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 Nature
  • ⏱ Reading Time:
  • 30 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 68%

Nature - T cell responses to SARS-CoV-2 spike cross-recognize Omicron

Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Cape Town, South Africa

Division of Medical Virology, Department of Pathology, University of Cape Town; Observatory, Cape Town, South Africa School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South AfricaNational Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South AfricaSA MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaDepartment of Medicine, University of Cape Town and Groote Schuur Hospital; Observatory, Cape Town, South...

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

Nature /  🏆 64. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Vaccines Elicit Highly Conserved Cellular Immunity to SARS-CoV-2 Omicron - NatureNature - Vaccines Elicit Highly Conserved Cellular Immunity to SARS-CoV-2 Omicron
Baca lebih lajut »

Vaccines Elicit Highly Conserved Cellular Immunity to SARS-CoV-2 Omicron - NatureNature - Vaccines Elicit Highly Conserved Cellular Immunity to SARS-CoV-2 Omicron
Baca lebih lajut »

Can cannabis protect people from COVID? Buzzy studies can't say.Can cannabis protect people from COVID? Buzzy studies can't say.A new study cannot say whether CBD or other cannabis products are helpful against the virus, while researchers call for clinical trials.
Baca lebih lajut »



Render Time: 2025-04-11 15:51:15